Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RLS-1496 Topical Cream for Actinic Keratosis
NCT07340697Phase 2Active, not recruiting
- Start
- Feb 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RLS-1496 in actinic keratosis (AK). Started Feb 2026; status: active, not recruiting.
02
Drugs
RLS-1496
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT07340697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340697.